Tetracyclines continue to be a cornerstone in the treatment of bacterial infections and inflammatory conditions, offering broad-spectrum efficacy and well-established clinical performance.
Our tetracycline APIs are developed and manufactured at our own GMP-certified sites in Europe, combining technical expertise, strong regulatory support, and reliable production.
Lymecycline: A Well-Tolerated Second-Generation Tetracycline
Lymecycline is a second-generation oral tetracycline prodrug known for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria. It is widely used in the treatment of acne and other susceptible bacterial infections, particularly where good tolerability is essential.
Its pharmacokinetic and safety profile offers key advantages:
- Rapid absorption with high bioavailability
- Once-daily dosing convenience
- Favorable gastrointestinal tolerability
- Enhanced intracellular penetration due to its lipophilicity
These characteristics make Lymecycline a trusted option in both dermatological and general anti-infective therapies.
Manufacturing Excellence Across Our European Sites
Suanfarma’s Lymecycline API is manufactured at our GMP-certified sites in Europe, ensuring:
- Compliance with the European Pharmacopoeia (EP) monograph
- Consistent quality and batch-to-batch reproducibility
- Full regulatory support and documentation (CoA, GMP, CEP)
- A robust and reliable global supply chain
With extensive commercial experience and dedicated technical and customer support, Suanfarma is a reliable partner for the development and supply of high-quality tetracycline APIs.
